Catalog No. | Product Name | Summary | Targets | CAS Number | Smiles |
A1337 | U0126-EtOH | MEK1/2 inhibitor | MAPK Signaling|MEK1/2 | 1173097-76-1 | CCO.C1=CC=C(C(=C1)N)SC(=C(C#N)C(=C(N)SC2=CC=CC=C2N)C#N)N |
A1901 | Q-VD-OPh hydrate | Cell-permeable, irreversible pan-caspase inhibitor | Apoptosis|Caspase | 1135695-98-5 | CC(C)C(C(=O)NC(CC(=O)O)C(=O)COC1=C(C=CC=C1F)F)NC(=O)C2=NC3=CC=CC=C3C=C2 |
A2571 | Pepstatin A | Aspartic proteinases inhibitor | Proteases|Other Proteases | 26305-03-3 | CC(C)CC(C(CC(=O)O)O)NC(=O)C(C)NC(=O)CC(C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(C(C)C)NC(=O)CC(C)C)O |
A3195 | Asunaprevir (BMS-650032) | NS3 protease inhibitor | Proteases|HCV Protease | 630420-16-5 | CC(C)(C)C(C(=O)N1CC(CC1C(=O)NC2(CC2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C |
A3618 | MK-5172 | HCV NS3/4a protease inhibitor | Proteases|NS3/4a protease | 1350514-68-9 | COC1=CC2=C(N=C(CCCCC[C@@H]3C[C@H]3OC(N[C@@H](C(C)(C)C)C(N4[C@H](C(N[C@@]5(C(NS(=O)(C6CC6)=O)=O)[C@H](C5)C=C)=O)C[C@@H]7C4)=O)=O)C(O7)=N2)C=C1 |
A4032 | VX-222 (VCH-222, Lomibuvir) | NNI of HCV RNA polymerase | Proteases|HCV Protease | 1026785-59-0 | CC1CCC(CC1)C(=O)N(C2CCC(CC2)O)C3=C(SC(=C3)C#CC(C)(C)C)C(=O)O |
A8458 | Lamivudine | Nucleoside analog reverse transcriptase inhibitor | Microbiology & Virology|Reverse Transcriptase | 134678-17-4 | C1C(OC(S1)CO)N2C=CC(=NC2=O)N |
B1580 | OG-L002 | LSD1 inhibitor, potent and specific | Chromatin/Epigenetics|Histone Demethylases | 1357302-64-7 | C1C(C1N)C2=CC=C(C=C2)C3=CC(=CC=C3)O |